Actively Recruiting
Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
Led by Chinese University of Hong Kong · Updated on 2024-08-27
600
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators aim to evaluate the diagnostic accuracy of FIT and the novel panel of four bacterial gene markers collectively named as M3, to detect recurrent advanced adenomas in patients with history of colonic adenomas.
CONDITIONS
Official Title
Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Known colorectal adenomas during index colonoscopy
- Available baseline M3 and FIT results before index colonoscopy
- Aged 18 years or older
- Written informed consent obtained
You will not qualify if you...
- Refusal or unfit to undergo surveillance colonoscopy
- Incomplete colonoscopy, incomplete removal of colorectal adenomas, or inadequate bowel preparation (Boston Bowel Preparation Scale score 0 or 1 in any colonic segment) at index colonoscopy
- Previous colonic resection
- Personal history of colorectal cancer
- Personal history of polyposis syndrome
- Personal history of inflammatory bowel disease
- Known pregnancy or lactation
- Advanced comorbid conditions (American Society of Anesthesiologists grade 4 or above)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
Actively Recruiting
Research Team
M
Min Dai
CONTACT
C
Connie Seto
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here